BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Xeljanz 11mg modified-release tablets 1001030ABBBACAD	Xeljanz	Tofacitinib	Musculoskeletal and Joint Diseases	No data available
Xeljanz 5mg tablets 1001030ABBBAAAB	Xeljanz	Tofacitinib	Musculoskeletal and Joint Diseases	No data available
Yuflyma 20mg/0.2ml inj pre-filled syringes 1001030S0BHAEAF	Yuflyma	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Yuflyma 40mg/0.4ml inj pre-filled syringes 1001030S0BHABAE	Yuflyma	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Yuflyma 40mg/0.4ml solution for injection pre-filled pens 1001030S0BHAAAD	Yuflyma	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Yuflyma 80mg/0.8ml inj pre-filled syringes 1001030S0BHADAG	Yuflyma	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Yuflyma 80mg/0.8ml solution for injection pre-filled pens 1001030S0BHACAH	Yuflyma	Adalimumab	Musculoskeletal and Joint Diseases	No data available
Zanaflex 2mg tablets 1002020T0BCAAAB	Zanaflex	Tizanidine hydrochloride	Musculoskeletal and Joint Diseases	No data available
Zanaflex 4mg tablets 1002020T0BCABAA	Zanaflex	Tizanidine hydrochloride	Musculoskeletal and Joint Diseases	No data available
Zessly 100mg pdr for concentrate for inf vials 1001030T0BFAAAA	Zessly	Infliximab	Musculoskeletal and Joint Diseases	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.